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The aim of this study is to investigate the concentrations of ethyl
glucuronide (EtG) in oral fluid and both EtG and ethyl sulfate (EtS)
in blood and urine following intense use of mouthwash and
ingestion of nonalcoholic wine, which are proven to contain
3 mg/L EtG, 1.5 mg/L EtS, and 0.2 g/L ethanol. Twelve subjects
participated in a controlled experiment. All subjects ingesting
nonalcoholic wine showed urine samples negative for EtG but
positive for EtS (Cmax 2.15 mg/L). All four subjects using
mouthwash were negative for EtG and EtS in urine. All samples of
oral fluid were negative for EtG and all samples of blood were
negative for EtG and EtS. This study showed that ingestion of EtG
and EtS as components of nonalcoholic wine lead to detection of
urine EtS only, suggesting superior bioavailability of orally ingested
EtS compared to EtG. This possibility of false-positive EtS results in
urine after ingestion of nonalcoholic wine is important to
remember when using EtG and EtS as relapse markers for alcohol.
Finally, the study showed that a positive EtG or EtS result after
accidental alcohol exposure is unlikely in blood and oral fluid.
Introduction
In a situation like workplace drug testing, verification of al-
cohol intake could be desirable. Traditionally, this is done by
measuring ethanol in blood, breath, or urine, but because
ethanol is cleared rapidly from the body, only very recent in-
takes could be detected (1,2). Therefore, the non-oxidative
ethanol metabolites ethyl glucuronide (EtG) and ethyl sulfate
(EtS) are increasingly used for this purpose (3). Used as relapse
markers, they are most frequently measured in urine, where
they have a detection time of approximately 24 h after ingestion
of a low dose of ethanol or up to five days after ingestion of
large, repeated doses (4,5).
Oral fluid has become an important alternative to urine as a
matrix in drug testing programs (6,7), and we have recently
suggested the use of this medium to test for alcohol ingestion
by measurement of EtG. Firstly, the introduction of oral fluid
makes the sampling procedures easier to perform and supervise
compared to urine. Secondly, oral fluid reflects the presence of
alcohol or drugs in blood better than urine (8–10). According
to a recently performed study, this is also the situation for
EtG (11).
One problem when using EtG and EtS as relapse markers for
alcohol ingestion is the possibility of having too good of a sen-
sitivity for some purposes, as EtG and EtS could also be de-
tected after incidental ingestion of alcohol. Three papers have
previously tried to assess this problem, indicating levels of
EtG in urine of about 0.1–0.3 mg/L after intense exposure to
mouthwash or hand sanitizers (12–14). To the authors’ knowl-
edge, no such published data exist for EtG or EtS measured in
blood or oral fluid. In addition, it is theoretically possible that
direct ingestion of EtG and EtS in the absence of ethanol, a sit-
uation possible in nonalcoholic wines, could yield positive EtG
and EtS results, which leads to a false assumption of alcohol in-
gestion. This question has, to the authors’ knowledge, not so
far been addressed in the literature.
The aim of this study is to investigate the possibility of such
“false-positive” EtG results in oral fluid, and both EtG and EtS
results in blood and urine from two sources: the use of al-
cohol-containing mouthwash and ingestion of nonalcoholic
wine proven to contain EtG and EtS.
Materials and Methods
Study protocol
Twelve healthy volunteers (four men and eight women) with
a median age of 22 years (range 19–30) and a median body
mass index of 22.0 kg/m2 (range 18.4–26.0) participated in a
controlled drinking experiment. They were all social drinkers
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with a median use of 12 standard drinks/month (range 4–20)
and had abstained from alcohol during the week preceding
the study, according to self-reports. Exclusion criteria were
somatic or psychiatric illness and use of regular medication.
After an overnight fast, samples of oral fluid, blood, and
urine were collected before start of the study. The participants
were then divided into three groups. In the first group, four
subjects rinsed their mouths with 15 mL of Listerine® mouth-
wash, containing 21.6% ethanol, for about 1 min and expec-
torated, followed by a 30-s break. This was repeated eight
times, which resulted in a total amount of 120 mL over 5 min
and exposure of a total dose of 20.7 g ethanol. The partici-
pants were instructed not to swallow the fluid. In the second
group, another four subjects ingested one bottle (7.5 dL) of
nonalcoholic wine (St. Regis Cabernet Sauvignon, Inglenook
Vineyards, Madera, CA), which was determined by liquid chro-
matography–tandem mass spectrometry (LC–MS) to contain
3.0 mg/L EtG and 1.5 mg/L EtS. The intake occurred over a 1-
h period. Two subjects only consumed 4.2 and 5.1 dL, respec-
tively, due to nausea. This nonalcoholic wine also contained
0.2% ethanol, which was determined by headspace gas chro-
matography equipped with a flame-ionization detector (15). In
the last group, the last four participants ingested a dose of
ethanol approximately equivalent to that present in one bottle
of nonalcoholic wine. Vodka containing 60% ethanol was used,
and 3.75 mL was ingested in one gulp (dose 1.8 g ethanol). The
vodka was analyzed by ultra-performance liquid chromatog-
raphy (UPLC)–MS–MS and was confirmed to not contain EtG
or EtS.
Samples of oral fluid, blood, and urine were collected at 1.5,
3.5, 5.5, and 7.5 h after intake. At the last time point, only sam-
ples of oral fluid and urine were collected. Oral fluid was col-
lected using a Statsure Saliva Sampler (Saliva Diagnostic Sys-
tems, Brooklyn, NY). Urine was collected in Sterilin tubes
without any additives, and for the blood samples, 5-mL Vacu-
tainer tubes containing 20 mg fluoride and 143 I.U. heparin
were used. All samples were stored at 4°C immediately after
sampling, followed by storage at –20°C until analysis. Because
of limitations in the analytical method, oral fluid samples were
only analyzed for EtG (11), and blood and urine samples were
analyzed for both EtG and EtS.
No food and drink apart from water was ingested until 1.5 h
after start of intake. Then, meals consisting of bread, cheese,
ham, and drinks were consumed at 1.5 and 5.5 h after intake.
The participants were not allowed to consume any other food
during the study period.
The subjects gave informed consent, and the study protocol
was approved by the National Committee for Research Ethics
in Norway and the Directorate for Health and Social Affairs.
Measurement of ethanol and creatinine
Alcohol was determined by an enzymatic method in oral
fluid, blood, and urine (16). The creatinine concentration in
urine was determined according to a previously published
method (17).
Measurement of EtG in oral fluid
EtG was determined in oral fluid using a previously pub-
lished method (11). Analysis of EtS in oral fluid was not pos-
sible with this method. The limit of detection (LOD) for EtG in
oral fluid was 0.0022 mg/L, and the limit of quantification
(LOQ) was 0.0044 mg/L. These values were for the oral
fluid/buffer mixture.
Measurement of EtG and EtS in blood and urine
Chemicals. EtG and EtG-d5 (internal standard) were supplied
by MEDICHEM® (Steinenbronn, Germany). EtS and EtS-d5
(internal standard) were supplied by Lipomed (Cambridge,
MA). HPLC-grade methanol and acetonitrile for UV–HPLC
were purchased from LAB-SCAN (Dublin, Ireland). Formic
acid (98%) was purchased from VWR International (Fontenay
sous Bois, France). Deionized water was obtained from a Milli-
Q UF Plus water purification system (Millipore, Bedford, MA).
Whole human blood was supplied from the blood bank at Ull-
evaal University Hospital (Oslo, Norway).
Preparation of standards. Stock standard solutions of EtG
and EtS were prepared in methanol and working standard so-
lutions were prepared in water from the stock solution. Spiked
whole blood and urine samples were prepared from the
working standard solutions at the concentration ranges: 0.1–
20 mg/L in blood and 1.1–44 mg/L in urine for EtG, 0.03–6
mg/L in blood and 0.6–25 mg/L in urine for EtS.
Sample preparation. For blood, an aliquot of 200 µL whole
blood was added to 50 µL internal standard solution (11 mg/L
EtG-d5 and 3 mg/L EtS-d5) and 1 mL cold methanol. The sam-
ples were immediately agitated for 1 min and put in the deep-
freezer for a minimum of 10 min. The samples were cen-
trifuged at 4°C at 4500 rpm for 10 min. The methanol layer was
transferred to a 5-mL glass tube and evaporated to dryness at
50°C under N2. The residue was reconstituted with 60 µL ace-
tonitrile/25 mM formic acid mixture (1:99, v/v), frozen, and
centrifuged again at 4500 rpm for 10 min. The supernatant was
transferred to autosampler vials.
For urine, an aliquot of 100 µL urine was added to 100 µL in-
ternal standard solution (same as previously) and 400 µL water.
The samples were mixed for 10 min and centrifuged at 4°C at
4500 rpm for 10 min. Clear extract was transferred to the au-
tosampler vials.
Instrumentation. The samples were analyzed by UPLC–MS–
MS. LC was performed using an integrated system fromWaters
(Milford, MA) with an Acquity™ Ultra Performance LC. Chro-
matographic separation was performed at 65°C on an Acquity
UPLC® HSS T3 column (2.1 × 100 mm, 1.8-µm particle size)
using gradient elution with a mobile phase consisting of 25
mM formic acid (A) and methanol (B). The flow rate was 0.4
mL/min. A gradient was carried out starting from 1% B, in-
creased to 20% over the next 2 min, then increased to 90%
within 0.01 min and maintained for 2.99 min before returning
to its initial conditions within 0.5 min. Total run time was 3.5
min. Injection volume was 2.5–3 µL.
MS detection was performed on a Waters Quattro Premier
XE triple-quadrupole MS. Ionization was achieved using elec-
trospray in the negative mode (ESI–) and multiple reaction
monitoring (MRM). The source block temperature was 120°C,
and the capillary voltage was 1 kV. The desolvation gas (ni-
trogen) was heated to 400°C, and the flow was set to 1000 L/h.
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The cone gas (nitrogen) was delivered at a flow rate of 50 L/h.
In the collision cell, the collision gas (argon) flow was 0.35
mL/min, and the pressure was 9.5e-3 mbar. Data acquisition,
peak integration, and calculation were interfaced to a computer
workstation running MassLynx 4.1 SCN627 software (Waters).
The following MRMs were used for detection: EtG 221.0 >
84.7, EtS 124.7 > 96.7, EtG-d5 226.0 > 85.0, and EtS-d5 129.7
> 97.7. Cone voltages were 35 V for both analytes and internal
standards. The retentions time was 1.8 min for EtG and EtG-
d5 and 1.1 min for EtS and EtS-d5.
Validation. Quantitative results were obtained by integrating
the peak height of the specific MRM trace in reference to the
integrated height of the internal standard. LOD and LOQ in
blood were 0.03 mg/L and 0.06 mg/L for EtG and 0.007 mg/L
and 0.02 mg/L for EtS, respectively. In urine, LOD and LOQ
were 0.17 mg/L and 0.37 mg/L for EtG and 0.06 mg/L and
0.16 mg/L for EtS, respectively. The values were calculated as
a mean of background noise + 3 standard deviations (SD) and
+10 SD, respectively. Day-to-day variations were in the range
of 8–14% (EtG: 0.12 and 13.5 mg/L, EtS: 0.04 and 4.2 mg/L) in
blood and 11–12% (EtG: 1.3 and 22.4 mg/L, EtS: 0.8 and 12.7
mg/L) in urine. Intraday variations at the same concentration
levels were between 3.6% and 8.7% in blood and 1.8% and
5.6% in urine. The EtG and EtS calibration curves were linear
with correlation coefficients greater than 0.9996 for both an-
alytes.
For EtG and EtS results in oral fluid, blood, and urine, re-
sults greater than LOD are reported as positive, and results less
than LOD are reported as negative. Quantitative results are
only reported if they were more than LOQ.
Statistics. All data were handled using the Kinetica (version
4.4) pharmacokinetic program (Thermo Fisher Scientific,
Waltham, MA). Statistic parameters were calculated using
SPSS (version 14.0, Chicago, IL).
Results
One subject in the nonalcoholic wine group (the one only in-
gesting 5.1 dL) showed EtG in urine before the start of drinking
and was, therefore, excluded. Otherwise, all samples were neg-
ative for ethanol, EtG, and EtS before start of the study.
Results from blood and oral fluid
All samples of blood and oral fluid were negative for ethanol,
EtG, and EtS in all three groups.
Results from urine
All samples were negative for ethanol in all three groups.
In the group ingesting nonalcoholic wine, all three subjects
were negative for EtG in urine but positive for EtS (Table I).
Of the four subjects ingesting 3.75 mL 60% vodka in one
gulp, two subjects showed positive samples of EtG and EtS in
urine. The Cmax values in the first subject were 0.62 mg/L for
EtG and 0.16 mg/L for EtS (normalized to 1000 mg/L creati-
nine), and this was reached after 3.5 h. The creatinine con-
centration was high in this sample (3028 mg/L). In the second
subject, the Cmax values were 0.29 mg/L for EtG and 0.23
mg/L for EtS, and this was also reached after 3.5 h. The two
other subjects ingesting this dose of ethanol were negative for
EtG and EtS in urine.
All urine samples in the four subjects using mouthwash
were negative for EtG and EtS.
Discussion
This study showed that accidental alcohol exposure did not
lead to a false-positive EtG or EtS results in blood or oral fluid.
It also showed that direct ingestion of EtG and EtS from non-
alcoholic wine did not result in positive EtG but did show EtS
concentrations up to 2.15 mg/L in urine.
False positives for EtG were neither found in blood nor oral
fluid. This was as expected, considering the much lower con-
centrations of EtG in blood and even lower concentrations in
oral fluid compared to urine (4,11). Therefore, the use of a
higher cutoff level in oral fluid is not necessary, and the lack of
such a source of error is an advantage when using oral fluid in-
stead of urine to verify alcohol ingestion by the use of EtG.
This study also showed that the direct ingestion of EtG did
not lead to positive results in oral fluid, blood, or urine, while
direct ingestion of EtS did lead to positive results in urine. The
amount directly ingested was approximately 2 mg EtG and 1
mg EtS, corresponding to the amount obtained after ingestion
of 10–15 g of ethanol, according to studies which measured the
total fraction of EtG and EtS excreted in urine (4). After such
a dose of ethanol, positive levels of EtG in urine would be ex-
pected because concentrations between 0.4 and 3.7 mg/L were
previously found after ingestion of 9 g ethanol (20). In an-
other study, concentrations of EtG ranged between 0.6 and
8.4 mg/L after ingestion of 7 g of ethanol in a fasted state (21).
The results from the present study therefore indicate that EtG
ingested orally does not have 100% bioavailability. Regarding
Table I. Urine Samples Positive for EtS in the Three
Subjects Ingesting Nonalcoholic Wine
Time After Start EtS
Subject* of Drinking (h) EtG (mg/L)†
1 1.5 negative 0.25
3.5 negative 1.16
5.5 negative 0.88
7.5 negative 0.66
2 3.5 negative 1.30
5.5 negative 2.15
7.5 negative 1.12
3 3.5 negative 1.12
5.5 negative 1.03
7.5 negative 0.66
* Subjects 1 and 2 ingested 7.5 dL, and subject 3 ingested 4.2 dL.
† Concentrations normalized to 1000 mg/L creatinine.
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EtS, 9 g of ethanol has led to concentrations of EtS between 2.0
and 11.1 mg/L (22), and the present work indicates enhanced
bioavailability for EtS compared to EtG. The reason for this is
unknown, but differing sizes and other properties of the
molecule could be a possible explanation. These results are im-
portant in the practical use of EtG and EtS as relapse markers
and show that EtS, which was previously assumed to be the
most reliable of the two metabolites (23,24), could be falsely in-
creased in urine after ingestion of nonalcoholic wine (25).
The ingestion of 3.75 mL vodka (1.8 g) was marginally larger
than the amount present in one bottle of nonalcoholic wine
and was performed to make up for the ethanol present in non-
alcoholic wine. Considering our findings, the positive EtS re-
sults after the nonalcoholic wine ingestion are most likely
caused by the directly ingested EtS, not conversion from the
ethanol present as the EtS levels obtained were approximately
ten times higher than the EtS levels obtained after drinking the
actual amount of ethanol. On the other hand, we cannot ex-
clude that a very small fraction of the EtS level was a result of
conversion from alcohol.
Also, we showed that ingestion of a minimal dose of ethanol
did yield positive EtG and EtS results in urine in two out of
four subjects. Considering a previous publication where up to
0.35 mg/L EtG in urine was seen after ingestion of 1 g of
ethanol (26), this was likely to happen. One could question why
this dose of ethanol resulted in positive findings, while inges-
tion of the same amount of ethanol from the nonalcoholic
wine did not. One explanation was that the ingestion of the
nonalcoholic wine occurred over a 1-h period, which resulted
in lower peak concentrations of ethanol compared to the same
dose ingested in one gulp. Also, the actual urine samples had
relatively high concentrations of creatinine, which could be an-
other explanation for the positive results.
This study did not confirm the previous positive results of
EtG in urine after intense use of mouthwash. Our LOD and
LOQ in urine (0.17 and 0.37 mg/L, respectively) are similar to
previously published levels (0.1–0.3 mg/L) after incidental al-
cohol exposure (12,13), but the exposure to the alcohol might
have been less intense. Our laboratory has also set a cutoff
level for EtG in urine (1.1 mg/L), as a result of the previous
publications regarding use of mouthwash. The present study
showed that this cutoff level was high enough to avoid such
false-positive results for EtG in urine. But according to pre-
vious studies, it would not shorten the detection times for
proper alcohol ingestion with a long time period (5,27).
The possibility of positive EtG results after incidental ethanol
exposure, such as use of mouthwash, is an equivalent to the de-
tection of morphine after ingestion of poppy seeds, which oc-
curs in urine but not in blood. On the other hand, ingestion of
poppy seeds has led to detection of morphine in oral fluid (28).
This is not surprising considering the high pKa value, excellent
transfer of opiates into saliva, and subsequent higher concen-
trations in oral fluid (8). In contrary, EtG has a much lower pKa
value (3.21) (29), which leads to much lower concentrations in
oral fluid. Positive results in oral fluid were therefore less
likely.
In conclusion, this study showed that the possibility of false-
positive results for EtG is unlikely in oral fluid and blood. EtG
in oral fluid could therefore be used to detect alcohol ingestion
in, for instance, workplace drug testing without fearing false-
positive results after accidental alcohol exposure. Also, we
showed that the bioavailability after direct oral ingestion is
better for EtS than for EtG. False-positive urine result for EtS
but not for EtG could therefore be seen after ingestion of non-
alcoholic wine.
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